Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 295.5 | 86 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 275.0 | 54 | |
N2759 | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 292.5 | 80 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 272.0 | 70 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 313.5 | 74 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 292.5 | 78 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 286.0 | 61 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 203.5 | 74 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 224.0 | 83 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 212.0 | 79 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 226.0 | 99 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 205.0 | 84 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 215.0 | 83 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 199.5 | 66 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 205.0 | 81 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 315.0 | 86 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 316.0 | 68 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 345.0 | 77 | |
N2759 | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 329.5 | 72 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 336.5 | 72 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 349.0 | 77 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 350.0 | 73 | |
N2586 | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 304.0 | 63 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 286.0 | 71 | |
RA1869 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 321.0 | 65 |